2019
DOI: 10.1038/s41598-019-53965-x
|View full text |Cite
|
Sign up to set email alerts
|

Febuxostat, a Xanthine Oxidoreductase Inhibitor, Decreases NLRP3-dependent Inflammation in Macrophages by Activating the Purine Salvage Pathway and Restoring Cellular Bioenergetics

Abstract: The nucleotide-binding oligomerization domain–like receptor family, pyrin domain–containing 3 (NLRP3) inflammasome mediates caspase-1 activation and IL-1β processing and is implicated in autoinflammatory as well as other chronic inflammatory diseases. Recent studies have demonstrated that xanthine oxidoreductase (XOR) inhibition attenuated IL-1β secretion in activated macrophages, but the detailed mechanism of inhibition remains unclear. In this study, we report that febuxostat, an inhibitor of XOR, suppressed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
20
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(26 citation statements)
references
References 27 publications
1
20
0
1
Order By: Relevance
“…The concentration of febuxostat used in the present study was lower than clinical concentration. Since recent report suggested that febuxostat at highest concentration of 200 μM could suppress the NLRP3 inflammasome 37) , we need further study to clarify this point.…”
Section: Discussionmentioning
confidence: 93%
“…The concentration of febuxostat used in the present study was lower than clinical concentration. Since recent report suggested that febuxostat at highest concentration of 200 μM could suppress the NLRP3 inflammasome 37) , we need further study to clarify this point.…”
Section: Discussionmentioning
confidence: 93%
“…Therefore, mitochondria constitutively produce ROS. A recent study has reported that inhibition of xanthine oxide reductase (XDH/XO) by febuxostat causes the increment of intracellular ATP by purine salvage pathway and reduces the production of ROS from MRC under normoxic conditions [47]. Thus, febuxostat may affect the production and activation of MMPs by reducing ROS derived from MRC under normoxic conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Dihydrorhodamine (DHR) 123 was already reported to be used for evaluation of mitochondrial ROS production in different cell lines including platelets [27][28][29][30][31][32]. In this study, DHR123 was applied for the evaluation of mito-…”
Section: Analysis Of Intra-platelet Ros Generationmentioning
confidence: 99%